Sunnyvale, California (CA) Pharmaceutical Preparations Companies

Featured companies
Pharmacyclics Inc
995 E Arques Ave.
Sunnyvale CA 94085
(408) 774-0330
Admunex Therapeutics Inc
140 S Wolfe Rd.
Sunnyvale CA 94086
(408) 245-0003
American Peptide Co
777 E Evelyn Ave.
Sunnyvale CA 94086
(408) 733-7604
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Aravasc Inc
1520 Samedra St.
Sunnyvale CA 94087
(408) 482-6835
Pharmacyclics Inc
995 East Arques Avenue
Sunnyvale CA 94085
(408) 774-0330

Pharmacyclics Inc is a publicly held company in Sunnyvale, CA and is a Headquarters business.
Quadriga Biosciences
1111 West El Camino Real
Sunnyvale CA 94087
Sorbent Therapeutics
710 Lakeway Drive # 290
Sunnyvale CA 94085
(408) 738-8440
Theratrophix LLC
365 San Aleso Avenue
Sunnyvale CA 94085
(650) 759-8898
Velocity Pharmaceutical Devmnt
1230 Bordeaux Drive
Sunnyvale CA 94089
(408) 744-1455
Adds Pharmaceuticals
1278 Reamwood Avenue
Sunnyvale CA 94089
(408) 744-0268
Adiana Inc
1240 Elko Drive
Sunnyvale CA 94089
Akzo Nobel Inc
1257 Tasman Drive # C
Sunnyvale CA 94089
(408) 752-1800
Vitaganic Inc
1275 Reamwood Avenue
Sunnyvale CA 94089
(408) 728-9636
Whereorg has 16 results under Pharmaceutical Preparations Companies in Sunnyvale, CA.

Narrow down the browsing criteria below to see more companies.

Other locations for category Pharmaceutical Preparations


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020